PYXS

Pyxis Oncology Inc
1.59
-0.01 (-0.63%)

Pyxis Oncology Inc. (PYXS) Fundamentals

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
SHARE INFORMATION
Market Cap$ 54,049,774
Shares Outstanding35,097,256
Float34,744,933
Percent Float99.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -9.45
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions121
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months1,035,675
Institutional Holdings Percent65.8%
Institutional Sold Previous 3 Months1,818,482
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent6.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,289,402
TRADING INFO
52 Week High$ 10.58
52 Week Low$ 1.10
52 Week High Change$ -84.68
21 Day Moving Average$ 1.4348
21 Day Extended Moving Average$ 1.4551
50 Day Moving Average$ 1.3707
50 Day Extended Moving Average$ 1.47
200 Day Moving Average$ 2.1624
200 Day Extended Moving Average$ 2.906
10 Day Average Volume32,005
20 Day Average Volume49,912
30 Day Average Volume93,680
50 Day Average Volume170,675
Alpha-0.129842
Beta0.7500
Standard Deviation0.152269
R20.096368
7 Day Price Change$ 0.09
7 Day Percent Change6.21%
21 Day Price Change$ 0.15
21 Day Percent Change10.79%
30 Day Price Change$ 0.26
30 Day Percent Change20.31%
Month to Date Price Change$ 0.20
Month to Date Percent Change14.93%
Quarter to Date Price Change$ 0.20
Quarter to Date Percent Change14.93%
180 Day Price Change$ -1.17
180 Day Percent Change-43.17%
200 Day Price Change$ -1.22
200 Day Percent Change-44.2%
Year to Date Price Change$ 0.20
Year to Date Percent Change14.93%

Pyxis Oncology Inc. (PYXS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.30
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio10.60
Leverage Ratio1.10
Quick Ratio10.40
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ -127,382,309
Price to Sales0.00
Price to Free Cash-0.70
PE High Last 5 Years0.00
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-55.83
Return on Equity-172.95
Return on Capital-153.48

Pyxis Oncology Inc. (PYXS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOLara S. Sullivan
Emplyoees73
Last AuditUQ
CIK0001782223
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address35 CambridgePark Drive
Cambridge, MA 2140
Websitehttps://www.pyxisoncology.com
Facsimile-
Telephone+1 617 221-9059
Email-


Your Recent History
NASDAQ
PYXS
Pyxis Onco..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.